What is the prevalence of HIV-associated lipodystrophy in the US?

Updated: Sep 05, 2019
  • Author: David T Robles, MD, PhD, FAAD; Chief Editor: Dirk M Elston, MD  more...
  • Print

Wide variation exists in the literature regarding the prevalence of HIV lipodystrophy. Various studies show the prevalence rate of this syndrome is 2-60% in all patients who are HIV positive [37, 38] ; a 2007 meta-analysis found a prevalence rate of 14-40% in HIV-positive patients on highly active antiretroviral therapy (HAART). [39] In untreated patients with HIV infection, a 4% prevalence rate is reported. The incidence of associated new-onset hypercholesterolemia, hypertriglyceridemia, and hyperglycemia is 24%, 19%, and 5%, respectively.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!